Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic DepressionThe REVAMP TrialAugmentation With CBASP and BSP for Depression
- 1 November 2009
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 66 (11), 1178-88
- https://doi.org/10.1001/archgenpsychiatry.2009.144
Abstract
Previous studies have found that few chronically depressed patients remit with antidepressant medications alone. To determine the role of adjunctive psychotherapy in the treatment of chronically depressed patients with less than complete response to an initial medication trial. This trial compared 12 weeks of (1) continued pharmacotherapy and augmentation with cognitive behavioral analysis system of psychotherapy (CBASP), (2) continued pharmacotherapy and augmentation with brief supportive psychotherapy (BSP), and (3) continued optimized pharmacotherapy (MEDS) alone. We hypothesized that adding CBASP would produce higher rates of response and remission than adding BSP or continuing MEDS alone. Eight academic sites. Chronically depressed patients with a current DSM-IV-defined major depressive episode and persistent depressive symptoms for more than 2 years. Phase 1 consisted of open-label, algorithm-guided treatment for 12 weeks based on a history of antidepressant response. Patients not achieving remission received next-step pharmacotherapy options with or without adjunctive psychotherapy (phase 2). Individuals undergoing psychotherapy were randomized to receive either CBASP or BSP stratified by phase 1 response, ie, as nonresponders (NRs) or partial responders (PRs). Proportions of remitters, PRs, and NRs and change on Hamilton Scale for Depression (HAM-D) scores. In all, 808 participants entered phase 1, of which 491 were classified as NRs or PRs and entered phase 2 (200 received CBASP and MEDS, 195 received BSP and MEDS, and 96 received MEDS only). Mean HAM-D scores dropped from 25.9 to 17.7 in NRs and from 15.2 to 9.9 in PRs. No statistically significant differences emerged among the 3 treatment groups in the proportions of phase 2 remission (15.0%), partial response (22.5%), and nonresponse (62.5%) or in changes on HAM-D scores. Although 37.5% of the participants experienced partial response or remitted in phase 2, neither form of adjunctive psychotherapy significantly improved outcomes over that of a flexible, individualized pharmacotherapy regimen alone. A longitudinal assessment of later-emerging benefits is ongoing.Keywords
This publication has 46 references indexed in Scilit:
- Patient Preference as a Moderator of Outcome for Chronic Forms of Major Depressive Disorder Treated With Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or Their CombinationBritish Journal of Psychology, 2009
- Chronic forms of major depression are still undertreated in the 21st century: Systematic assessment of 801 patients presenting for treatmentJournal of Affective Disorders, 2008
- Combination Treatment for Acute Depression Is Superior Only when Psychotherapy Is Added to MedicationPsychotherapy and Psychosomatics, 2007
- Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side EffectsJournal of Psychiatric Practice, 2006
- A comparative trial of psychotherapy and pharmacotherapy for “pure” dysthymic patientsJournal of Affective Disorders, 2005
- The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionBiological Psychiatry, 2003
- The Treatment of Chronic Depression, Part 2Published by Physicians Postgraduate Press, Inc ,1998
- The Treatment of Chronic Depression, Part 3Published by Physicians Postgraduate Press, Inc ,1998
- Residual symptoms after partial remission: an important outcome in depressionPsychological Medicine, 1995
- Clinical Practice Guideline, Number 5. Depression in Primary CareJournal of Clinical Psychopharmacology, 1994